BlackRock and Barclays disclose stakes in Advanced Medical Solutions

what happened

Reuters reported two disclosures under Rule 8.3 of the UK Takeover Code concerning Advanced Medical Solutions Group plc. Both cover positions and dealings as of 22 October 2026.

BlackRock, Inc. controls 6,057,211 of the company's 5p ordinary shares, equal to 2.74%, and reported no short positions. The filing lists two purchases on that date: 1,135 shares at 2.8200 GBP and 2,174 shares at 2.8225 GBP. BlackRock said it has no voting authority over 73,759 shares, though it keeps investment discretion over them.

Barclays PLC separately disclosed 7,550,790 shares, or 3.42%, and 978,692 short shares, or 0.44%. Its total interest stood at 8,529,301 shares, or 3.86%, including cash-settled derivatives. Its dealings on 22 October included share purchases and sales at prices around 2.82 GBP, along with swap and CFD transactions.

why it matters

Rule 8.3 requires holders of at least 1% of a company's securities during an offer period to disclose their positions and trades. Such notices are routine, but they show that large institutions are actively trading the stock while the takeover process is under way. Changes in holdings below 1% have little direct weight for the wider market, so the interest is mainly among the company's shareholders.

market impact

Advanced Medical Solutions shares: large holders actively trading during the takeover process, impact limited to this stock.

tags

instruments